Aster DM Quality Care540975Board key decisions

Board approves conversion of INR 102.46 Cr loan in wholly owned arm into equity; O&M and medical services pacts with DMERF to be closed

Board approved converting a pre-existing loan of INR 102.46 Cr given to Sri Sainatha Multispeciality Hospitals (wholly owned subsidiary) into 10,24,62,779 equity shares of INR 10 each.

By ScoutQuest · Fri 6 Nov 2026, 7:40 PM IST · 3 min read

Loan converted to equity: INR 102.46 Cr
Equity shares issued: 10,24,62,779 equity shares of INR 10 each
Revenue contribution of unit: 0.40% of the total revenue of the group in the last financial year

What the Board approved

Conversion of a pre-existing loan of INR 102.46 Cr extended by the Company to Sri Sainatha Multispeciality Hospitals Private Limited, a wholly owned subsidiary, into equity shares.
Sri Sainatha will issue 10,24,62,779 equity shares of face value INR 10/- each to the Company.
The conversion is based on a valuation report from Krol Advisory Private Limited.
This is described as part of internal capital restructuring, with no fresh infusion of funds by the Company into the subsidiary.
Indicative time period for completion: within 3 months.
The Company continues to hold 100% of the equity share capital of Sri Sainatha; there is no change in ownership or control.

What the loan conversion means

A loan sitting on the books as money receivable becomes share capital in the subsidiary. The Company does not put in new cash; it swaps a claim it already had into ownership shares. The update states the conversion is proposed on an arm's length basis.

About the subsidiary

Name: Sri Sainatha Multispeciality Hospitals Private Limited, incorporated 24 May 2007, in India, in the healthcare industry.
Paid-up share capital: INR 7,01,59,380 divided into 1000 Class A equity shares of INR 10/- each aggregating to INR 10,000/- and 70,14,938 Class B equity shares of INR 10/- each aggregating to INR 7,01,49,380/-.
Authorised share capital: INR 10,10,58,850/-.
Turnover: FY 2025-26 INR79.43 Cr, FY 2024-25 74.74 crore, FY 2023-24 59.55 crore.

Second decision: agreements with DMERF to be closed

The Board approved termination/closure of the Operation & Management Services Agreement dated 4 March 2016 (as amended and extended) and the Medical Services Agreement dated 1 April 2026, both entered into with DM Education and Research Foundation.
Operations the Company undertook under these agreements will consequently cease.
The termination is proposed by mutual consent, subject to execution of termination/closure documents and settlement of respective rights, obligations and outstanding dues between the parties.
Expected date of completion shown as 06 November 2026.
Stated reason: in line with corporate governance priorities, efforts are being made to reduce related party transactions within the Group, and the closure of both agreements will eliminate the ongoing stream of related party transactions with DMERF.
The unit/division concerned contributed 0.40% of the total revenue of the group in the last financial year.
No consideration is receivable, as the existing agreements are being cancelled.

Shareholder approval

The Board also approved seeking shareholders' approval for special business through a Postal Ballot and the related Notice. The Notice of Postal Ballot will be sent to shareholders and stock exchanges in due course.

How a reader can weigh this

The loan conversion is an internal, cash-neutral step: an existing receivable becomes equity in a 100%-owned subsidiary, so ownership does not change.
The agreement closures end a stream of related party transactions with DMERF, which the update links to corporate governance priorities; the operations concerned were 0.40% of group revenue.
The termination is proposed and remains subject to execution of closure documents and settlement of dues.

Also from Aster DM Quality Care